Core Insights - The Clorox Company (CLX) reported strong fourth-quarter fiscal 2025 results, with both revenue and earnings exceeding expectations and showing year-over-year growth [1][3][4] - The company is advancing its long-term strategy with the rollout of a new U.S. enterprise resource planning (ERP) system aimed at enhancing growth and efficiency [2][15] Financial Performance - Adjusted earnings per share (EPS) reached $2.87, surpassing the Zacks Consensus Estimate of $2.24, marking a 57.7% increase from $1.82 in the same quarter last year [3] - Net sales totaled $1.99 billion, a 4.5% increase year-over-year, driven by an 8-point increase in volume, partially offset by a 4-point decline in price mix [4] - Organic sales grew by 8% year-over-year [4] Segment Performance - The Health and Wellness segment saw a 14% increase in sales to $741 million, driven by an 18-point increase in volume [6] - The Household segment reported a 7% increase in net sales to $639 million, with a 13-point increase in volume [7] - The Lifestyle segment's sales grew by 3% to $339 million, reflecting an 8-point increase in volume [8] - The International segment experienced a 1% decline in net sales to $269 million, despite a 5-point increase in volume [9] Gross Profit and Margins - Gross profit increased by 4.5% year-over-year to $924 million, with a gross margin remaining flat at 46.5% [5] - Incremental ERP shipments contributed approximately 150 basis points to gross margin [5] Future Guidance - For fiscal 2026, net sales are expected to decline by 6% to 10%, with organic sales anticipated to decrease by 5% to 9% due to the reversal of incremental shipments from the previous year [16][19] - Adjusted EPS is projected to be between $5.95 and $6.30, indicating a decline of 18% to 23% from the previous year [20]